Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

0.4013

-0.0242 (-5.69%)

At close: Nov 6, 2026, 4:00 PM EST

0.4065

+0.0052 (1.30%)

After-hours: Nov 6, 2026, 6:05 PM EST

Akebia Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	197.2	236.2	160.18	194.62	292.48	211.65
Revenue Growth	-12.38%	47.46%	-17.70%	-33.46%	38.19%	-28.17%
Gross Profit	159.83	195.84	134.03	154.86	269.99	130.16
Operating Income	-20.09	26	-46.21	-44.5	-34.64	-227.88
Net Income	-44.56	-5.35	-69.41	-51.93	-94.23	-282.02
Earnings Per Share	-0.17	-0.02	-0.33	-0.28	-0.52	-1.70
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	159.25	184.84	51.87	42.93	90.47	149.8
Total Debt	206.77	198.78	188.73	144.28	157.27	189.13
Net Cash (Debt)	-47.52	-13.94	-136.86	-101.35	-66.8	-39.33
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.18	-0.05	-0.65	-0.54	-0.37	-0.24

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	15.78	67.99	-40.66	-23.38	-73.15	-252.97
Capital Expenditures	-1.92	-0.29	-0.03	-	-0.11	-0.06
Free Cash Flow	13.86	67.7	-40.69	-23.38	-73.27	-253.02
Free Cash Flow Growth	-56.92%	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	81.05%	82.92%	83.68%	79.57%	92.31%	61.50%
Operating Margin	-10.19%	11.01%	-28.85%	-22.86%	-11.84%	-107.67%
Pretax Margin	-21.90%	-1.58%	-43.33%	-26.68%	-32.22%	-133.25%
Profit Margin	-22.60%	-2.26%	-43.33%	-26.68%	-32.22%	-133.25%
FCF Margin	7.03%	28.66%	-25.40%	-12.02%	-25.05%	-119.55%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	82.56	18.72	18.72	18.72	18.72
P/FCF Ratio	8.04	6.31	-	-	-	-
PS Ratio	0.57	1.81	2.59	1.20	0.36	1.87